1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Physciosporin suppresses mitochondrial respiration, aerobic glycolysis, and tumorigenesis in breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
2019) In Clinical cancer research : an official journal of the American Association for Cancer Research 25(23). p.7139-7150(
- Contribution to journal › Article
- 2018
-
Mark
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer : meta-analysis of individual patient data from ten randomised trials
- Contribution to journal › Article
- 2017
-
Mark
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
(
- Contribution to journal › Article
- 2015
-
Mark
Adjuvant bisphosphonate treatment in early breast cancer : meta-analyses of individual patient data from randomised trials
- Contribution to journal › Article
- 2014
-
Mark
Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma
(
- Contribution to journal › Article
- 2012
-
Mark
Comparisons between different polychemotherapy regimens for early breast cancer : meta-analyses of long-term outcome among 100,000 women in 123 randomised trials
- Contribution to journal › Article
- 2011
-
Mark
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen : patient-level meta-analysis of randomised trials
- Contribution to journal › Article
- 2010
-
Mark
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
- Contribution to journal › Article
- 2001
-
Mark
Timing of quality of life (QoL) assessments as a source of error in oncological trials
(
- Contribution to journal › Article